Program
GK01
A development code. Also written as “GK01 Injection” and “GK01 injection”.
Its studies are mostly in Lung Neoplasms, led by Beijing Geekgene Technology.
Furthest: phase 1, since Mar 16, 20264 company-led studies, 4 open or runningNext primary completion: Dec 2026 (phase 1)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Beijing Geekgene Technology | 44 open or running | phase 1since Mar 16, 2026 | Feb 5, 2026 | Dec 2026phase 1 · NCT07482319 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Feb 5, 2026First studies: 2 early phase 1 studies in Advanced Solid TumorsFirst studyNCT07414316, NCT07412665
- Mar 16, 2026Phase 1 study in Advanced Solid TumorsNCT07482319 · 15 planned · China
- Jun 23, 2026Early phase 1 study in Advanced Lung CancerNCT07673419 · 10 planned · China
Ahead
- Dec 2026Primary completion: phase 1 study in Advanced Solid TumorsNCT07482319
- Feb 12, 2027Primary completion: early phase 1 study in Advanced Solid TumorsNCT07414316
- Mar 31, 2027Primary completion: early phase 1 study in Advanced Solid TumorsNCT07412665
- Jun 2028Primary completion: early phase 1 study in Advanced Lung CancerNCT07673419
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07673419Advanced Lung Cancer · China | Early 1 | Not yet recruiting | Jun 2028 | 10 |
| NCT07482319Advanced Solid Tumors · China | 1 | Not yet recruiting | Dec 2026 | 15 |
| NCT07412665Advanced Solid Tumors · China | Early 1 | Not yet recruiting | Mar 31, 2027 | 10 |
| NCT07414316Advanced Solid Tumors · China | Early 1 | Recruiting | Feb 12, 2027 | 10 |
How it is read
Names in the registry
- “GK01 Injection”, 2 entries
- “GK01 injection”, 2 entries
Codes read as this program: GK01.
Conditions, from the studies’ own filings
- Lung Neoplasms, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.